Short Fermentation Cycle and High Productivity
Optimization of the coenzyme system and flux control dramatically reduces the reaction time, leading to a shorter cycle time and higher volumetric productivity .
1,4-Butanediol (1,4-BDO) is a critical chemical building block for the production of high-value polymers (e.g., PBT, THF). Current production methods present major drawbacks: chemical synthesis generates large amounts of pollution and relies on fossil feedstocks, while initial biosynthesis routes suffer from a long fermentation cycle and low productivity. This necessitates a sustainable, high-productivity bio-route.
CD Biosynsis offers advanced metabolic engineering to achieve efficient, bio-based 1,4-BDO production. Our core strategy involves modification of the Clostridium metabolism pathway —a powerful anaerobic host—to maximize carbon flux towards 1,4-BDO. Critically, this is coupled with optimization of the coenzyme regeneration system to overcome redox bottlenecks and accelerate the entire biosynthetic cascade. We provide a genetically stable, high-titer Clostridium strain capable of short-cycle, high-purity 1,4-BDO synthesis.
Get a QuoteThe transition to bio-based 1,4-BDO production is hampered by the following microbial limitations:
Our comprehensive strategy must address both the metabolic flux inefficiency and the coenzyme regeneration bottleneck within this specialized host.
CD Biosynsis employs a strategy of metabolic and enzyme engineering to establish a robust and high-yield 1,4-BDO bioproduction platform in Clostridium:
Modification of the Clostridium Metabolism Pathway
We use advanced gene editing to de-bottleneck the central carbon pathway and delete major solvent/acid formation pathways (butanol, butyrate, acetate), redirecting maximum flux toward 1,4-BDO synthesis.
Optimization of the Coenzyme Regeneration System
We specifically engineer the host's central metabolism and introduce high-efficiency NAD(P)H-generating enzymes to overcome the severe redox imbalance, ensuring a continuous supply of reducing power for the 1,4-BDO pathway.
Pathway Enzyme Overexpression and Tuning
The heterologous pathway enzymes responsible for the conversion from succinyl-CoA to 1,4-BDO are codon-optimized and highly overexpressed to maximize flux, while their ratio is tuned to prevent intermediate accumulation.
Product Toxicity and Strain Stability Engineering
We modify the host membrane or introduce efficient product efflux systems to improve tolerance to 1,4-BDO , preventing product toxicity, ensuring stable growth, and maintaining high productivity over long periods.
This integrated approach leverages the natural anaerobic power of Clostridium while systematically eliminating the bottlenecks inherent in the synthetic pathway.
Choosing CD Biosynsis's 1,4-BDO engineering service offers the following core value:
Short Fermentation Cycle and High Productivity
Optimization of the coenzyme system and flux control dramatically reduces the reaction time, leading to a shorter cycle time and higher volumetric productivity .
Reduced Environmental Pollution
Bioproduction eliminates the reliance on hazardous chemicals and high temperatures used in petrochemical synthesis, significantly reducing waste and environmental impact .
Superior Anaerobic Host (Clostridium)
Clostridium is naturally adept at anaerobic fermentation, making it a robust, low-energy host perfect for large-scale, low-oxygen bioreactors .
Low-Cost Feedstock Flexibility
Clostridium can often utilize a variety of low-cost C5/C6 sugars or lignocellulosic biomass hydrolysates, providing flexibility and reducing raw material costs.
High Yield and Purity
Deletion of competing pathways ensures that the highest possible proportion of the substrate is converted to the final 1,4-BDO product, maximizing yield and purity.
We provide the enabling technology for a clean, efficient, and profitable bio-based 1,4-BDO industry.
CD Biosynsis's 1,4-BDO strain engineering service follows a standardized research workflow, ensuring every step is precise and controllable:
Technical communication is maintained throughout the process, focusing on timely feedback regarding productivity and stability improvements.
Secure a high-performance, green source for 1,4-Butanediol! CD Biosynsis provides customized strain engineering solutions:
Why is Clostridium an ideal host for 1,4-BDO?
Clostridium species are naturally powerful anaerobic fermenters that utilize the CoA-dependent pathway, which can be efficiently leveraged to synthesize 1,4-BDO intermediates. This allows for low-energy, high-yield production under simple anaerobic conditions.
What is the main challenge related to the long fermentation cycle?
The long cycle is often caused by the accumulation of the final product (1,4-BDO) to toxic levels, which inhibits cell growth and metabolism. Our strategy includes engineering the strain for higher product tolerance to maintain cell health and high flux for longer periods.
How do you optimize the coenzyme regeneration system?
We boost regeneration by upregulating native or heterologous enzymes that produce NAD(P)H from the central metabolism, ensuring that the high demand from the 1,4-BDO reduction steps is continuously met, thus preventing the pathway from stalling.
Does the final product require extensive purification?
By genetically deleting competing solvent and acid pathways (e.g., butanol, butyrate), the engineered strain produces 1,4-BDO with much fewer co-fermented byproducts than native Clostridium. This significantly simplifies and lowers the cost of downstream purification.
What is the estimated project timeline?
A complex project involving specialized host genetic manipulation, multi-enzyme pathway optimization, and high-titer anaerobic fed-batch validation typically requires 20-24 weeks for final strain delivery.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.